Trial Profile
PRULIFLOXACIN VERSUS LEVOFLOXACIN IN PATIENTS WITH ACUTE BACTERIAL RHINOSINUSITIS ABRS
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2016
Price :
$35
*
At a glance
- Drugs Prulifloxacin (Primary) ; Levofloxacin
- Indications Bacterial infections; Rhinosinusitis
- Focus Therapeutic Use
- Sponsors Angelini Group
- 09 Nov 2016 Status changed from recruiting to completed.
- 30 Jun 2011 This trial is recruiting in Hungary and Spain and has been completed in Italy and Austria.
- 30 Jun 2011 New trial record